Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Breast Neoplasms 15Pancreatic Neoplasms 13Colorectal Neoplasms 10Rectal Neoplasms 7Stomach Neoplasms 6Neoplasm Metastasis 6Lung Neoplasms 6Neoplasms 5Recurrence 4Ovarian Neoplasms 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3Prostatic Neoplasms 3Lymphoma, T-Cell, Peripheral 3Leukemia, Myeloid, Acute 3Esophageal Squamous Cell Carcinoma 3Colonic Neoplasms 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Treatment 2Solid Tumor 2Small Cell Lung Cancer Limited Stage 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Lymphoma 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2

Interventions

sonidegib 1glucoraphanin 1Transurethral Resection of Prostate 1Tissue Banks 1Specimen Handling 1Saline Solution 1Ropivacaine 1Robotic Surgical Procedures 1Pancreaticoduodenectomy 1Glucose 1Genetic Testing 1Electroporation 1Drug Therapy 1Conversion to Open Surgery 1Contrast Media 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pancreatic Ductal Adenocarcinoma × Drug Therapy × Clear all
NCT05611359 2022-11-10

HOPE-1

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Not yet recruiting
60 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡